Ulrik B. Nielsen
General Partner at Mission Biocapital
About
A general partner in Cambridge and seasoned entrepreneur with deep expertise in therapeutic innovation and drug development. He co-founded Tidal Therapeutics, acquired by Sanofi in 2021, and Torque Therapeutics, and was Chief Scientific Officer at Merrimack Pharmaceuticals where his team advanced five cancer therapeutics into clinical development.
Investments
Board seats
Alloy Therapeutics, Inc.
As listed on the firm's website.
Colleagues at Mission Biocapital
Cassidy Blundell
Partner at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Clay Rowland
Investment Associate at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital
Josephine Brysting
Investment Analyst at Mission Biocapital